Secondary Logo

Institutional members access full text with Ovid®

Prevalence, Macrolide Resistance, and Fluoroquinolone Resistance in Mycoplasma genitalium in Men Who Have Sex With Men Attending an Sexually Transmitted Disease Clinic in Dublin, Ireland in 2017–2018

Mulligan, Vanessa, MSc*†; Lynagh, Yvonne, MSc*; Clarke, Susan, MB; Unemo, Magnus, PhD§; Crowley, Brendan, MD

Sexually Transmitted Diseases: April 2019 - Volume 46 - Issue 4 - p e35–e37
doi: 10.1097/OLQ.0000000000000940
Notes
Buy

This is the first prevalence study of Mycoplasma genitalium and antimicrobial resistance study in Ireland. In urine samples from men who have sex with men (n = 400) attending a sexually transmitted disease clinic in Dublin, the prevalence of M. genitalium was 3% (12 of 400 specimens; 95% confidence interval, 1.3–4.7%), and the prevalences of macrolide resistance (75%), fluoroquinolone resistance (33.3%), and multidrug resistance (33.3%) were very high.

The prevalence of Mycoplasma genitalium was 3% (12 of 400 specimens; 95% confidence interval, 1.3–4.7%) in urine samples from men who have sex with men in Dublin, Ireland, with 75% of samples resistant to macrolides and 33% resistant to fluoroquinolones.

From the *Department of Microbiology, St James's Hospital;

Dublin Institute of Technology;

Gay Men's Health Service, Baggot Street Hospital, Dublin, Ireland;

§WHO Collaborating Centre for Gonorrhoeae and other STIs, Department of Laboratory Medicine, Örebro University, Örebro, Sweden;

Department of Virology, St James's Hospital, Dublin, Ireland

Conflicts of Interest: None declared.

Sources of Funding: This work was supported by funds from the laboratory at St James's Hospital.

Correspondence: Brendan Crowley, MD, Department of Virology, St James's Hospital, Dublin, Ireland. E-mail: bcrowley@stjames.ie.

Received for publication August 10, 2018, and accepted October 29, 2018.

© Copyright 2019 American Sexually Transmitted Diseases Association